Diplomat to Present at Investor Conferences in February, March 2019
FLINT, Mich., Feb. 12, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) executives will participate in four upcoming investor conferences.
Brian Griffin, chairman and CEO, and Atul Kavthekar, chief financial officer, will represent the company at these events:
- 8th Annual SVB Leerink Global Healthcare Conference in New York: Feb. 27 at 9 a.m. ET
- Raymond James 40th Annual Institutional Investors Conference in Orlando: March 4 at 4 p.m. ET
- Cowen and Company 39th Annual Health Care Conference in Boston: March 11 at 1:30 p.m. ET
- Barclays Global Healthcare Conference in Miami: March 14 at 8:30 a.m. ET
Live audio webcasts of each presentation will be available on the investor relations section of Diplomat's website at ir.diplomat.is. Audio recordings will be available online for approximately 30 days following each presentation.
To learn more about Diplomat, visit diplomat.is.
Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in this patient care expertise, Diplomat also serves payers through CastiaRx, a leading specialty benefit manager, and offers tailored solutions for healthcare innovators through EnvoyHealth. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues — always focused on improving patient care. For more information, visit diplomat.is.
Terri Anne Powers, Vice President of Investor Relations
312.889.5244 | email@example.com
Elizabeth Carr, Corporate Communications Manager
810.768.9871 | firstname.lastname@example.org
View original content to download multimedia:http://www.prnewswire.com/news-releases/diplomat-to-present-at-investor-conferences-in-february-march-2019-300794033.html
SOURCE Diplomat Pharmacy, Inc.